Expression of P-glycoprotein in pregnant rats after treatment with rifampicin, dexamethasone, St John's wort and thyroxine

被引：0
|
作者：
Lederer, K [1 ]
Möritz, KU [1 ]
Siegmund, W [1 ]
机构：
[1] Univ Greifswald, Peter Holtz Res Ctr Pharmacol & Expt Therapeut, Dept Clin Pharmacol, D-17487 Greifswald, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2004年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
408
引用
收藏
页码：R102 / R102
页数：1
相关论文
共 50 条
  • [1] Effects of Rifampicin, Dexamethasone, St. John's Wort and Thyroxine on Maternal and Foetal Expression of Abcb1 and Organ Distribution of Talinolol in Pregnant Rats
    Salje, Karen
    Lederer, Kirstin
    Oswald, Stefan
    Dazert, Eike
    Warzok, Rolf
    Siegmund, Werner
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 (02) : 99 - 105
  • [2] A role for P-glycoprotein expression and function in drug interactions with St John’s Wort
    Irish Journal of Medical Science, 2001, 170 (Suppl 2)
  • [3] St John's Wort increases expression of P-glycoprotein: Implications for drug interactions
    Hennessy, M
    Kelleher, D
    Spiers, JP
    Barry, M
    Kavanagh, P
    Back, D
    Mulcahy, F
    Feely, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (01) : 75 - 82
  • [4] Modulation of P-Glycoprotein function by St John's wort extract and its major constituents
    Webre, CC
    Kressmann, S
    Fricker, G
    Müller, WE
    PHARMACOPSYCHIATRY, 2004, 37 (06) : 292 - 298
  • [5] Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol
    Schwarz, U. I.
    Hanso, H.
    Oertel, R.
    Miehlke, S.
    Kuhlisch, E.
    Glaeser, H.
    Hitzl, M.
    Dresser, G. K.
    Kim, R. B.
    Kirch, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) : 669 - 678
  • [6] Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin
    Wang, EJ
    Barecki-Roach, M
    Johnson, WW
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (01) : 123 - 128
  • [7] In vitro activity of St. John's wort against cytochrome P450 isozymes and P-glycoprotein
    Foster, BC
    Sockovie, ER
    Vandenhoek, S
    Bellefeuille, N
    Drouin, CE
    Krantis, A
    Budzinski, JW
    Livesey, J
    Arnason, JT
    PHARMACEUTICAL BIOLOGY, 2004, 42 (02) : 159 - 169
  • [8] Lymphocyte P-glycoprotein expression and activity before and after rifampicin in man
    Becquemont, L
    Camus, M
    Eschwege, V
    Barbu, V
    Rey, E
    Funck-Brentano, C
    Jaillon, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2000, 14 (05) : 519 - 525
  • [9] St John's Wort modulates both expression and function of P glycoprotein in peripheral blood lymphocytes
    Hennessy, M
    Feely, J
    Kelleher, D
    Mulcahy, F
    Barry, M
    AIDS, 2000, 14 : S95 - S95
  • [10] St. John's wort induces intestinal P-glycoprotein and intestinal and hepatic CYP3A4.
    Dürr, D
    Steiger, B
    Kullak-Ublick, G
    Rentsch, K
    Steinert, H
    Meier, PJ
    Fattinger, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P9 - P9
12345